About: Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 1997 (uk) im Oktober 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 1997 (ast) scientific article published on 01 October 1997 (en)
publication date	wds:Q79898946-E4ACE9DF-7195-4756-827F-DC3AFD5800D7
publication date	1997-10-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q79898946-707D5AB9-8886-4A87-AFCE-D198AD9BB5B4 wds:Q79898946-C91E4AB4-0C4B-4B40-BA76-D9FDA05424D4 wds:Q79898946-EB13210A-BCD4-4E65-9AD2-6B79082F8C58
author name string	S Schneeweiss J Hasford M Goettler
rdfs:label	Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission (en) Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission (nl)
skos:prefLabel	Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission (en) Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission (nl)
name	Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission (en) Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission (nl)
title	wds:Q79898946-7A0FE061-E9AD-4E46-8CDD-A77DB65072AD
title	Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission (en)
page(s)	wds:Q79898946-06D5E371-1721-44DF-B3E9-368C72E12B04
page(s)	S79-90
instance of	wds:Q79898946-1072C0ED-E715-496D-B51B-3F084480E03E
instance of	scholarly article
PubMed ID	wds:Q79898946-A65E3E72-0642-4897-A8A0-99EA80AF8042
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15073758
PubMed ID	15073758
published in	wds:Q79898946-5091797C-E33B-4069-BABE-42D07C014EA6
published in	Pharmacoepidemiology and Drug Safety
volume	wds:Q79898946-65E62667-BB12-41B0-B7AB-59A777C7CA53
volume	6 Suppl 3
DOI	wds:Q79898946-AF13FAA6-B4C6-4008-BC98-9258E80BC20A
DOI	http://dx.doi.org/10.1002/(SICI)1099-1557(199710)6:3%2B%3CS79::AID-PDS294%3E3.3.CO;2-F
DOI	10.1002/(SICI)1099-1557(199710)6:3+<S79::AID-PDS294>3.3.CO;2-F
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q79898946
is cites work of	Methods and systems to detect adverse drug reactions in hospitals [Detection and evaluation of adverse drug reactions] Identification of adverse drug events: the use of ICD-10 coded diagnoses in routine hospital data Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions--a meta-analysis Adverse drug reactions as a cause for admissions to a department of internal medicine Prescription peer academic detailing to reduce inappropriate prescribing for older patients: a cluster randomised controlled trial Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions How are the costs of drug-related morbidity measured?: a systematic literature review Factors predicting hospital readmissions related to adverse drug reactions Preventability of drug-related harms - part I: a systematic review Methods for assessing the preventability of adverse drug events: a systematic review Emergency department visits caused by adverse drug events: results of a French survey. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study Hospitalizations due to preventable adverse reactions-a systematic review Health care use and costs of adverse drug events emerging from outpatient treatment in Germany: a modelling approach A cost-effectiveness analysis of an in-hospital clinical pharmacist service Public pharmacovigilance communication: a process calling for evidence-based, objective-driven strategies Prevalence and perceived preventability of self-reported adverse drug events--a population-based survey of 7099 adults Modelling drug-related morbidity in Sweden using an expert panel of physicians Modelling drug-related morbidity in Sweden using an expert panel of pharmacists'. Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study [Medical and socio-economical impact of drug-induced adverse reactions] Preventable drug-related morbidity in community pharmacy: development and piloting of a complex intervention. Evaluation of cost of treatment of drug-related events in a tertiary care public sector hospital in Northern India: a prospective study Focusing on risk communication about medicines: why now? Drug-Related Morbidity in Brazil: A Cost-of-Illness Model Adverse drug reaction monitoring in Jena--experiences of a regionalized pharmacovigilance centre The need for a comprehensive medication safety module in medical education How to improve communication for the safe use of medicines?: Discussions on social marketing and patient-tailored approaches at the annual meetings of the WHO Programme for International Drug Monitoring. Estimation of time devoted to adverse drug reactions assessment in an internal medicine department Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults
is cites work of	wds:Q33914501-CE8DE463-0390-4AD1-9C50-B5808DB21240 wds:Q28481506-89088E5E-F742-475D-B0AF-A917F0C2EA86 wds:Q34657198-076A4AA3-9776-44BE-B127-0712EFB396B2 wds:Q39817163-29F20465-E06D-48DC-BB21-11D2104FE4DF wds:Q37971470-084D2408-22AB-44DC-8BBD-C47A05CEDB7D wds:Q37798243-AAFC66C7-5C4C-4ED1-B9B4-634A3DCEAAC0 wds:Q37127336-E52D0705-F923-422E-99AD-7F8E8CFF5153 wds:Q37975521-9F9325D3-215F-4E72-946B-1B111B5A1613 wds:Q37173976-1023D5BA-F15B-4B41-AAF9-D36058DE62DA wds:Q46433555-3EC0EE00-4863-4A38-80DC-C1073BECC99D wds:Q43237199-5AD204B9-A356-4330-B04D-CDADFFAD1C89 wds:Q78073561-CDF9A41A-C7BB-40EB-9AED-19C43DF45EB9 wds:Q34458560-9A3AA02A-4678-4635-9085-29122A6E7945 wds:Q38004883-799C3E9B-708D-48E8-98D9-53AF8F55069E wds:Q35659813-CF8E82BA-DF43-4EEF-9BA2-82BC89F82B2A wds:Q47834552-D4BFC94F-7DCB-4DF9-9814-70BC9F647F2C wds:Q53015365-BBF5892E-60F5-4060-A7F3-A9C0B99D664A wds:Q28536709-60CA8949-961E-449F-AFEF-4B04BCA2B90D wds:Q33792583-E4A42CC5-1C07-4002-A2AB-623BD520C063 wds:Q37526527-BAC08FD2-C467-46F2-8DD7-CCAA2CD92B46 wds:Q34209590-9C5F0207-3643-46CE-AE93-915214EB793C wds:Q36535969-94D9B0E6-C51F-41FF-83F8-A1CC699BF959 wds:Q42758914-CB308908-16DC-4361-89A9-54E32E8C2CA5 wds:Q77745371-563CA286-7990-41DE-AB92-615544BF73D8 wds:Q78409167-5D0CE944-78D9-4C04-88E2-CE4CBD5D4755 wds:Q28080256-36B9426F-84E2-491D-87FC-491D2882FF74 wds:Q35582089-D7357E8B-9546-48DB-B00F-C2BEE88C94F3

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software